Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

Two non-synonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin

Onkar S. Bains, Morgan J. Karkling, Thomas A. Grigliatti, Ronald E. Reid and Kenneth Wayne Riggs
Drug Metabolism and Disposition February 9, 2009, DOI: https://doi.org/10.1124/dmd.108.024711
Onkar S. Bains
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morgan J. Karkling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas A. Grigliatti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald E. Reid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Wayne Riggs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1124/dmd.108.024711
PubMed 
19204081

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X

Article Versions

  • You are currently viewing an Earlier version of this article (February 9, 2009 - 08:31).
  • View the most recent version of this article

Author Information

Statistics from Altmetric.com

Article usage

Article usage: February 2009 to May 2022

AbstractFullPdf
Feb 200937082
Mar 200932060
Apr 2009281052
May 200946923
Jun 2009171315
Jul 200917410
Aug 200917516
Sep 2009231325
Oct 20092188
Nov 20091359
Dec 20093116
Jan 2010481016
Feb 201028417
Mar 20103175
Apr 20103944
May 2010191612
Jun 2010191515
Jul 2010221412
Aug 2010471212
Sep 201037157
Oct 2010231711
Nov 201017289
Dec 201073712
Jan 2011173117
Feb 2011181524
Mar 2011201811
Apr 2011162212
May 201191921
Jun 201161713
Jul 201116159
Aug 2011132117
Sep 2011141414
Oct 201111914
Nov 2011181315
Dec 2011171328
Jan 2012231022
Feb 2012171110
Mar 2012281312
Apr 2012101110
May 2012221725
Jun 201212125
Jul 2012111219
Aug 2012151314
Sep 2012131217
Oct 2012101418
Nov 201291729
Dec 2012171622
Jan 2013191617
Feb 2013133917
Mar 2013191128
Apr 2013111412
May 2013131014
Jun 201312107
Jul 201315159
Aug 20136227
Sep 20131498
Oct 201315124
Nov 20131686
Dec 2013896
Jan 2014682
Feb 2014888
Mar 2014101210
Apr 201410109
May 2014757
Jun 201411810
Jul 201416162
Aug 20141033
Sep 2014141
Oct 2014743
Nov 20146157
Dec 20142811
Jan 201514138
Feb 2015286
Mar 20151856
Apr 20151296
May 20156136
Jun 201512147
Jul 201518819
Aug 20151857
Sep 20151478
Oct 20151287
Nov 20151097
Dec 20151065
Jan 201612614
Feb 20169149
Mar 201612413
Apr 20161159
May 20161052
Jun 2016858
Jul 20161165
Aug 2016547
Sep 2016347
Oct 20161105
Nov 20163117
Dec 2016177
Jan 201703110
Feb 20171102
Mar 20176146
Apr 20171102
May 20170137
Jun 2017125
Jul 20172219
Aug 20170265
Sep 20170167
Oct 20172257
Nov 20172218
Dec 20173187
Jan 20180110
Feb 20181189
Mar 20180125
Apr 20180174
May 20180226
Jun 201801822
Jul 201811425
Aug 201801513
Sep 2018084
Oct 201801210
Nov 201801411
Dec 20181878
Jan 20191239
Feb 20191515
Mar 2019804
Apr 20194129
May 20192413
Jun 20191108
Jul 20192801
Aug 20191411
Sep 201916013
Oct 20191202
Nov 20196533
Dec 20192513
Jan 20201802
Feb 20201812
Mar 20201411
Apr 20201925
May 2020510
Jun 2020632
Jul 2020611
Aug 2020511
Sep 2020800
Oct 2020903
Nov 2020502
Dec 2020802
Jan 20211446
Feb 20212212
Mar 20212721
Apr 20211441
May 20211120
Jun 20212123
Jul 20211512
Aug 2021950
Sep 20211931
Oct 20211163
Nov 20211934
Dec 20211510
Jan 20221921
Feb 20221210
Mar 20221211
Apr 20221071
May 2022630

Next
Back to top

In this issue

Drug Metabolism and Disposition: 50 (5)
Drug Metabolism and Disposition
Vol. 50, Issue 5
1 May 2021
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Two non-synonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Two non-synonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin

Onkar S. Bains, Morgan J. Karkling, Thomas A. Grigliatti, Ronald E. Reid and Kenneth Wayne Riggs
Drug Metabolism and Disposition February 9, 2009, DOI: https://doi.org/10.1124/dmd.108.024711

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

Two non-synonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin

Onkar S. Bains, Morgan J. Karkling, Thomas A. Grigliatti, Ronald E. Reid and Kenneth Wayne Riggs
Drug Metabolism and Disposition February 9, 2009, DOI: https://doi.org/10.1124/dmd.108.024711
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics